We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
- Authors
Loprinzi, C L; Goldberg, R M; Su, J Q; Mailliard, J A; Kuross, S A; Maksymiuk, A W; Kugler, J W; Jett, J R; Ghosh, C; Pfeifle, D M
- Abstract
Hydrazine sulfate, an agent that appears to inhibit gluconeogenesis, has been studied in cancer patients for approximately 20 years. There was a recent resurgence of interest in this drug when subset analysis of a small placebo-controlled, double-blind, clinical trial reported improved survival among non-small-cell lung cancer patients with a good performance status who were randomized to receive this drug along with standard chemotherapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Vol 12, Issue 6, p1126
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1994.12.6.1126